Accuracy of botulinum toxin injections in myofascial pain. Response to Gobel et al. Pain 2006;125:82–8

References 

1. Gerwin RD, Dommerholt J, Shah JP. An expansion of Simons’ integrated hypothesis of trigger point formation. Curr Pain Headache Rep. 2004;8:468–475
   • MEDLINE
   • CrossRef
2. Gobel H, Heinze A, Reichel G, Hefter H, Benecke R. Dysport myofascial pain study group. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. Pain. 2006;125:82–88
   • Abstract
   • Full Text
   • Full-Text PDF (131 KB)
   • CrossRef
3. Reilich P, Pongratz D. Myofascial pain syndrome. In:  Jost WH editors. Botulinum toxin in painful diseases. Pain Headache. vol. 14:Basel: Karger; 2003;p. 23–41
4. Reilich P, Fheodoroff K, Kern U, Mense S, Seddigh S, Wissel J, et al. Consensus statement: botulinum toxin in myofascial pain. J Neurol. 2004;251(Suppl. 1):I36–I38
   • CrossRef
5. Simons DG, Travell JG, Simons LS. Travell Simons’ myofascial pain and dysfunction: the trigger point manual. Vol. 1: upper half of body. 2nd ed. Baltimore: Williams&Wilkins, 1999.